An Atlanta law firm is investigating Home Depot's planned layoff of nearly 800 Georgia workers, exploring a potential class-action lawsuit over whether the company violated federal notification laws.
While Las Vegas Sands shares have struggled to keep pace with the broader market, a majority of Wall Street analysts maintain a constructive outlook, betting on a recovery in Macau and the company's long-term integrated resort model.
Tether, the company behind the world's dominant stablecoin, has quietly built a balance sheet rivaling major financial institutions, amassing vast holdings of U.S. Treasury debt and gold. Its explosive growth is reshaping its role in traditional finance and drawing regulatory scrutiny.
Shareholders in Harley-Davidson's electric motorcycle spinoff, LiveWire Group, have seen their holdings erode dramatically over five years, with a recent $55 million weekly loss adding to the pain. The company's ongoing revenue contraction raises fundamental questions about its path to profitability in the competitive EV market.
Amidst a turbulent period for craft distilling, the founders of Casey Jones Distillery in Hopkinsville, KY, have sold their bourbon and moonshine operation to Pennsylvania-based B3 Beverage Company, securing the legacy of a family-run business while joining a growing portfolio of craft breweries and distilleries.
Tyson Foods reported a 6.2% increase in Q1 2026 sales to $14.3 billion, driven by robust demand for protein. While the Chicken and Prepared Foods segments showed strength, the company is restructuring its Beef operations, closing one plant and scaling back another, to align with a constrained cattle supply outlook.
The parent company of Fatburger and Round Table Pizza, along with its Twin Hospitality spinoff, will be removed from the Nasdaq exchange effective February 4, transitioning to the over-the-counter market following Chapter 11 filings and over $1 billion in debt.
Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.
After years of share price weakness, Immunocore Holdings (IMCR) appears significantly undervalued by traditional metrics. But does the market know something the models don't? We examine the DCF and P/S analyses, the company's unique T-cell receptor platform, and the risks that have kept investors wary.
Piper Sandler raises its price target on Kura Sushi USA (KRUS) following an investor meeting, citing potential from recent changes to its digital loyalty platform. The company also appointed a new marketing-focused director as it eyes U.S. expansion.
Freedom Capital initiates coverage on Mama's Creations (MAMA) with a Buy rating and a $16 price target, citing the company's expanding national footprint, product innovation, and strong recent earnings as key growth catalysts in the fresh meal sector.
IDEXX Laboratories reports robust fourth-quarter and full-year 2025 results, with double-digit revenue growth fueled by record instrument placements and strategic innovations like InVue DX and CancerDx. The company provides a confident outlook for 2026, targeting continued organic growth despite sector headwinds.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.
Despite recent guidance revisions, Mobileye Global retains strong buy ratings from analysts who see significant upside potential, as the company positions 2026 for a strategic transition in the autonomous driving sector.
Wells Fargo boosts its price target for Taysha Gene Therapies (TSHA), citing strong progress in its pivotal Rett syndrome gene therapy program. The company has dosed the first patient in a key trial phase and received FDA alignment on its regulatory pathway.
Apis Capital's flagship fund, which surged 55% in 2025, spotlights clinical-stage biotech Celcuity in its latest investor letter, citing the company's novel platform for matching cancer patients with targeted therapies.
Amphenol Corporation (NYSE: APH), a key player in electronic connectors, received concurrent price target increases from Seaport Research and Citi. While analysts highlight growth potential, the stock's post-earnings dip underscores a cautious market stance toward the company's traditionally conservative guidance.
Needham raises Nova Ltd. (NVMI) to Buy with a $500 price target, citing improving industry conditions and the company's strategic position in China's memory market. The upgrade follows a similar bullish move by Bank of America earlier in January.
Oracle is launching a massive $45-$50 billion capital raise to aggressively expand its cloud infrastructure, fueled by long-term contracts with AI giants like OpenAI, NVIDIA, and Meta. The move underscores the fierce competition in the cloud arms race, even as the company's stock faces recent headwinds.
